Medical education reviewed by Domenico Savatta, MD, FACS on July 23, 2026; educational use only. Care routing remains closed.

Sleep-related hypoventilation guide

Obesity hypoventilation syndrome: carbon dioxide distinguishes it from OSA alone

OHS is obesity plus awake daytime hypercapnia after other causes of hypoventilation are excluded. Most affected people also have OSA, but OHS adds sustained ventilatory failure and greater cardiopulmonary risk, so oxygen saturation or an apnea count alone is insufficient.

Medically reviewed July 23, 2026 Clinical reviewer: Domenico Savatta, MD, FACS Educational use only

Direct answer

What is obesity hypoventilation syndrome?

OHS is defined in an adult with obesity by an awake arterial carbon-dioxide level of at least 45 mm Hg when medication, lung, chest-wall, neuromuscular, metabolic, and other causes do not better explain the hypoventilation. Sleep testing characterizes associated OSA and overnight gas exchange so treatment can be selected safely.

  • Body size alone does not diagnose OHS, and OHS should not be used as a stigmatizing label.
  • A normal spot oxygen reading does not reliably exclude elevated carbon dioxide.
  • Severe shortness of breath, confusion, blue lips, chest pain, or marked drowsiness can indicate acute respiratory failure and needs emergency care.

At a glance

  • Ask whether serum bicarbonate screening and arterial blood gas testing are appropriate.
  • Measure carbon dioxide directly when clinical suspicion is high.
  • Characterize OSA severity and nocturnal hypoventilation with an appropriate sleep study.
  • CPAP and noninvasive ventilation are selected based on stability, OSA severity, gas exchange, and response.
  • Weight-management care supports long-term improvement but does not replace urgent ventilatory treatment.

OHS is more than severe OSA

The defining abnormality is awake hypercapnia in the setting of obesity after exclusions.

OSA causes repeated obstruction during sleep. OHS reflects inadequate ventilation that persists into wakefulness. The two frequently coexist, and both can cause sleepiness, morning headache, and oxygen loss. Carbon-dioxide assessment and the broader respiratory evaluation prevent the conditions from being collapsed into one.

Symptoms can be subtle until illness

Chronic respiratory failure may be mistaken for ordinary fatigue or deconditioning.

Loud snoring, witnessed pauses, breathlessness, morning headache, edema, daytime sleepiness, reduced exercise tolerance, and signs of pulmonary hypertension can appear. Respiratory infection, surgery, oxygen, or sedating medication may precipitate acute worsening. Prior emergency visits or unexplained high bicarbonate deserve attention.

Screening and confirmation are different steps

Serum bicarbonate can guide who needs a blood gas in lower-risk settings.

ATS guidance describes using a bicarbonate threshold in selected patients with low-to-moderate suspicion, while obtaining arterial carbon dioxide directly when suspicion is high. Bicarbonate can be affected by diuretics and other acid-base conditions. The clinician interprets it with symptoms, oxygen, lung function, medicines, and examination.

The sleep study maps the nighttime phenotype

Treatment depends on obstruction, hypoventilation, gas exchange, and stability.

An attended study may record carbon dioxide along with airflow, effort, oxygen, sleep stage, and rhythm. Ask whether the report distinguishes episodic obstruction from sustained hypoventilation. Limited home testing may not answer a complex hypoventilation question.

PAP mode follows the clinical situation

Stable ambulatory OHS with severe OSA may begin differently from hospitalized respiratory failure.

ATS guidance supports PAP treatment and often CPAP first in stable ambulatory patients with coexisting severe OSA, with reassessment of symptoms and gas exchange. Noninvasive ventilation may be needed in other phenotypes or when CPAP is insufficient. Oxygen without adequate ventilation can worsen carbon-dioxide retention in susceptible people.

Long-term care needs multiple owners

Ventilation, cardiopulmonary disease, weight treatment, and perioperative planning intersect.

Coordinate sleep or pulmonary follow-up, primary care, obesity medicine, cardiology when indicated, and any surgery or anesthesia team. Effective and sustained weight loss can improve or resolve OHS in some people, but the current breathing disorder must remain treated and objectively monitored during that process.

Appointment checklist

Build an OHS evaluation that measures ventilation

Bring the findings that separate obstruction from chronic hypoventilation.

  1. 1

    Symptoms and events

    Record sleepiness, morning headache, breathlessness, edema, infections, hospitalizations, and sedative or oxygen exposure.

  2. 2

    Gas evidence

    Bring serum bicarbonate, arterial or venous blood gas interpretation, awake oxygen, and any overnight carbon-dioxide data.

  3. 3

    Sleep phenotype

    Record OSA severity, oxygen burden, sustained desaturation, hypoventilation, sleep stage, and treatment titration results.

  4. 4

    Alternative causes

    Review COPD, restrictive disease, neuromuscular or chest-wall disease, hypothyroidism, and respiratory-depressant medicines.

  5. 5

    Treatment response

    Define PAP mode, adherence, symptoms, repeat gas testing, weight-care owner, and emergency or hospitalization plan.

Common questions

Questions patients ask first

Is OHS the same as sleep apnea?

No. Most people with OHS also have OSA, but OHS specifically includes awake daytime carbon-dioxide retention after other causes are excluded.

Can a pulse oximeter diagnose OHS?

No. Oxygen does not directly measure carbon dioxide and a normal spot value cannot rule out hypoventilation.

Can CPAP treat OHS?

It is often first-line for stable ambulatory OHS with severe coexisting OSA, but response and gas exchange must be reassessed and some people need noninvasive ventilation.

Can weight loss cure OHS?

Sustained substantial weight loss can resolve OHS in some people. Breathing treatment should continue until a clinician proves it is no longer needed.

Authoritative sources

Review the public guidance

Medically reviewed by Domenico Savatta, MD, FACS on July 23, 2026. Source links support education, not a personal recommendation.